Skip to content

Autism Spectrum Disorders (Pervasive Developmental Disorders)

Featured Studies

Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the ClinicalTrials.gov registry, with the most recent studies appearing first.

  • Study of Toddlers With Language Delay.
    Evaluation study. The purpose of this study is to learn more about risk factors for autism by studying the behavior and brain functioning of toddlers with early communication delays and typically developing toddlers. Ages 10 months-20 months. Location in Bethesda, MD.
  • Screening for Studies on Autism Spectrum Disorders.
    Evaluation study. This study will screen children and adolescents (and their parents) to determine the child's eligibility for participation in NIMH research studies on autism spectrum disorders, such as autism and Rett's Disorder. Ages up to 20. Location in Bethesda, MD.
  • Long-Term Olanzapine Treatment in Children With Autism.
    Interventional study. This study will determine the short- and long-term safety and effectiveness of the drug olanzapine (Zyprexa®) for reducing symptoms of autism in children. Ages 3-12. Location in Philadelphia, PA.

Search ClinicalTrials.gov for other NIH studies on Autism Spectrum Disorders (Pervasive Developmental Disorders).